Calvin T Sung1, Maria A McGowan2, Sharon E Jacob3. 1. Medical Student III, School of Medicine, University of California, Riverside, Riverside, CA, USA. 2. Department of Dermatology, Loma Linda University, Loma Linda, CA, USA. 3. Department of Dermatology, Loma Linda University, 11370 Anderson Street, Suite 2600, Loma Linda, CA, 92354, USA. sjacob@contactderm.net.
Abstract
PURPOSE OF REVIEW: The environment for the developing children is complex as they are exposed to a variety of activities and settings where potential environmental allergens may be encountered. Recent evidence supports the clinical benefit of patch testing young children suffering from recalcitrant dermatitis. While patch testing has been recently approved by the Food and Drug Administration in children ages 6-18 years old, patch testing strategies for young children of preschool age (between 2 and 6 years old) have yet to be defined. RECENT FINDINGS: Allergic contact dermatitis is underdiagnosed among pediatric patients, particularly those suffering from concomitant atopic dermatitis as the interplay between the two diseases is complex. Recent reports in literature supported the clinical value, safety, and efficacy of patch testing pediatric patients. This review provides an overview of specific pediatric allergens, special considerations, practical modifications, and systematic exposure-driven guidance approaches toward patch testing preschoolers.
PURPOSE OF REVIEW: The environment for the developing children is complex as they are exposed to a variety of activities and settings where potential environmental allergens may be encountered. Recent evidence supports the clinical benefit of patch testing young children suffering from recalcitrant dermatitis. While patch testing has been recently approved by the Food and Drug Administration in children ages 6-18 years old, patch testing strategies for young children of preschool age (between 2 and 6 years old) have yet to be defined. RECENT FINDINGS: Allergic contact dermatitis is underdiagnosed among pediatric patients, particularly those suffering from concomitant atopic dermatitis as the interplay between the two diseases is complex. Recent reports in literature supported the clinical value, safety, and efficacy of patch testing pediatric patients. This review provides an overview of specific pediatric allergens, special considerations, practical modifications, and systematic exposure-driven guidance approaches toward patch testing preschoolers.
Authors: Ashley B Wentworth; James A Yiannias; James H Keeling; Matthew R Hall; Michael J Camilleri; Lisa A Drage; Rochelle R Torgerson; Debra D Fett; Amy V Prakash; Leigh Ann Scalf; Eve M Allen; Janis S Johnson; Nidhi Singh; Diane L Nordberg Linehan; Jill M Killian; Mark D P Davis Journal: J Am Acad Dermatol Date: 2013-11-20 Impact factor: 11.527
Authors: Alina Goldenberg; Nico Mousdicas; Nanette Silverberg; Douglas Powell; Janice L Pelletier; Jonathan I Silverberg; Jonathan Zippin; Luz Fonacier; Antonella Tosti; Leslie Lawley; Mary Wu Chang; Andrew Scheman; Gary Kleiner; Judith Williams; Kalman Watsky; Cory A Dunnick; Rachel Frederickson; Catalina Matiz; Keri Chaney; Tracy S Estes; Nina Botto; Michelle Draper; Leon Kircik; Aida Lugo-Somolinos; Brian Machler; Sharon E Jacob Journal: Dermatitis Date: 2016 Sep-Oct Impact factor: 4.845